Hasil Pencarian - Xiao-Fang Yi
- Menampilkan 1 - 7 hasil dari 7
-
1
-
2
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized contr... oleh Shu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, Li Sun, Jie-Tao Ma, Cheng-Bo Han
Diterbitkan 2023-08-01
Artikel -
3
-
4
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumor oleh Xiao-Fang Yi, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shu-Ling Zhang, Le-Tian Huang, Cheng-Bo Han, Jie-Tao Ma
Diterbitkan 2023-07-01
Artikel -
5
Efficacy and safety of sanjiezhentong capsules, a traditional chinese patent medicine, on long-term management of endometriosis: A randomized controlled trial oleh Jing-Yao Ruan, Yun-Xi Zheng, Qi Tian, Jun-Ya Ke, Li Wang, Yan Du, Zhi-Ling Zhu, Xiao-Fang Yi, Cong-Jian Xu
Diterbitkan 2021-01-01
Artikel -
6
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis fro... oleh Ruo-Lin Gao, Jun Song, Li Sun, Zhi-Xuan Wu, Xiao-Fang Yi, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han
Diterbitkan 2022-08-01
Artikel -
7
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analys... oleh Xiao-Fang Yi, Jun Song, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han
Diterbitkan 2022-06-01
Artikel